Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


People In Brief: Bayer, NPA, FTC

This article was originally published in The Tan Sheet

Executive Summary

Dekkers gives Bayer two more years; Hilmas joins NPA; Hobbs directs Rainbow Light science; McSweeney starts at FTC; Bayer’s Mann takes WMSI chair; Archambault leads Ropack development.

You may also be interested in...

NPA Dusts Off DSHEA Coalition To Expand Industry’s Political Clout

NPA is restarting the Coalition to Preserve DSHEA on its own and other supplement industry trade groups are welcome to join. “We’re going to pick up the pace and really work to gain access the way other FDA-regulated industries do,” says NPA President Daniel Fabricant.

Belgium Outlaws OTC Cough And Cold Combination Drugs

Safety concerns prompt Belgium's drug regulator to order all OTC fixed combination products for coughs and colds removed from shelves.

Allegations Of EU Notified Body Fees Having Escalated And Of Being Unpredictable

US medtech companies are worried EU notified bodies have too much freedom over setting their fees, accusing them of lacking transparency and being inconsistent with what they charge. They also allege that notified body practices mean some products will miss the four-year grace period.


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts